Neoplasms, Thyroid Recruiting Phase 1 / 2 Trials for Pralsetinib (DB15822)

Also known as: Thyroid malignancies / Thyroid Neoplasm / Thyroid Neoplasms / Thyroid Tumor / Thyroid malignancy / Thyroid tumour / Thyroid neoplasia / Neoplasm thyroid / Thyroid neoplasm NOS / Thryoid neoplasia / Neoplasm of thyroid gland (disorder)

IndicationStatusPhase
DBCOND0053997 (Neoplasms, Thyroid)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03037385Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Patients With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid TumorsTreatment